-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The production process of 3(2H)-pyridazinone,5-amino-(6CI,7CI,9CI) is a multi-step process that involves several chemical reactions and purification steps.
The final product is an important intermediate in the production of active pharmaceutical ingredients (APIs) and is used in several medications.
The production process can be broken down into the following steps:
- Raw material preparation: The production of 3(2H)-pyridazinone,5-amino-(6CI,7CI,9CI) begins with the preparation of raw materials.
This involves the synthesis of various starting materials, such as 2-amino-6-chloro-pyridazine and 2-amino-7-chloro-pyridazine, which are then reacted to form the desired product. - Coupling reaction: The next step in the production process is the coupling reaction, which involves the combination of the two amino-pyridazines to form the 3(2H)-pyridazinone scaffold.
This reaction is typically carried out in the presence of a strong acid catalyst, such as sulfuric acid, and can be monitored by TLC or HPLC to ensure completion. - Purification: After the coupling reaction is complete, the product is typically purified to remove any remaining impurities.
This can be achieved through several methods, including crystallization, chromatography, and recrystallization. - Hydrolysis: In some cases, the final product may be contaminated with impurities that need to be removed.
This can be achieved through hydrolysis, which involves treatment of the product with a strong acid or base to remove any unwanted impurities. - Characterization: The final step in the production process is the characterization of the product.
This involves several tests, such as spectroscopy and chromatography, to confirm the purity and identity of the final product.
The product may also be tested for stability, such as by subjecting it to temperature and pH changes, to ensure it is suitable for use in pharmaceutical applications.
The production of 3(2H)-pyridazinone,5-amino-(6CI,7CI,9CI) is a complex process that requires careful monitoring and control to ensure the production of a pure and stable final product.
The quality of the final product is critical, as it will be used in the production of active pharmaceutical ingredients (APIs) that are used to treat a variety of medical conditions.
Therefore, it is important that the production process is carried out in a controlled and consistent environment to ensure the quality of the final product.
Additionally, the production process must be scalable and cost-effective, as these factors will impact the overall cost of the final product and its availability to patients in need.